scholarly journals Lack of observed impact of history or concomitant treatment of seasonal allergies or rhinitis on repeated doses of diazepam nasal spray administered per seizure episode in a day, safety, and tolerability: Interim results from a phase 3, open-label, 12-month repeat-dose safety study

2021 ◽  
Vol 118 ◽  
pp. 107898
Author(s):  
Blanca Vazquez ◽  
James Wheless ◽  
Jay Desai ◽  
Adrian L. Rabinowicz ◽  
Enrique Carrazana
Keyword(s):  
Nasal Spray ◽  
Repeat Dose ◽  
Concomitant Treatment ◽  
Open Label ◽  
Safety Study ◽  
Phase 3 ◽  
Repeated Doses ◽  
Seizure Episode ◽  
Seasonal Allergies

scholarly journals Lack of observed tolerance to diazepam nasal spray (Valtoco®) after long-term rescue therapy in patients with epilepsy: Interim results from a phase 3, open-label, repeat-dose safety study

2021 ◽  
Vol 120 ◽  
pp. 107983
Author(s):  
Gregory D. Cascino ◽  
Daniel Tarquinio ◽  
James W. Wheless ◽  
R. Edward Hogan ◽  
Michael R. Sperling ◽  
...  
Keyword(s):  
Nasal Spray ◽  
Rescue Therapy ◽  
Repeat Dose ◽  
Open Label ◽  
Safety Study ◽  
Phase 3 ◽  
Patients With Epilepsy

scholarly journals Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: Results from an exit survey of a phase 3, open-label, repeat-dose safety study

2021 ◽  
Vol 121 ◽  
pp. 108013
Author(s):  
Patricia Penovich ◽  
James W. Wheless ◽  
R. Edward Hogan ◽  
Cynthia Guerra ◽  
David F. Cook ◽  
...  
Keyword(s):  
Nasal Spray ◽  
Repeat Dose ◽  
Open Label ◽  
Safety Study ◽  
Phase 3 ◽  
Exit Survey

Final results from a Phase 3, long‐term, open‐label, repeat‐dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy

Epilepsia ◽  
2021 ◽  
Author(s):  
James W. Wheless ◽  
Ian Miller ◽  
R. Edward Hogan ◽  
Dennis Dlugos ◽  
Victor Biton ◽  
...  
Keyword(s):  
Nasal Spray ◽  
Repeat Dose ◽  
Open Label ◽  
Safety Study ◽  
Phase 3 ◽  
Patients With Epilepsy

scholarly journals A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine

BMC Neurology ◽  
2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Angelo Camporeale ◽  
David Kudrow ◽  
Ryan Sides ◽  
Shufang Wang ◽  
Annelies Van Dycke ◽  
...  
Keyword(s):  
Open Label ◽  
Safety Study ◽  
Phase 3

scholarly journals DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study

2020 ◽  
Vol 47 (1) ◽  
pp. 48-54 ◽  
Author(s):  
Sabrina G. Fabi ◽  
Joel L. Cohen ◽  
Lawrence J. Green ◽  
Sunil Dhawan ◽  
Theda C. Kontis ◽  
...  
Keyword(s):  
Open Label ◽  
Safety Study ◽  
Phase 3 ◽  
Open Label Phase

Safety, tolerability, and efficacy of repeat-dose injections of incobotulinumtoxinA In the treatment of upper facial lines: Results from a prospective, open-label, phase 3 study

Toxicon ◽  
2018 ◽  
Vol 156 ◽  
pp. S60
Author(s):  
Martina Kerscher ◽  
Simon A. Connolly ◽  
Bernard Biwer ◽  
Petra Weissenberger ◽  
Philippe Kestemont ◽  
...  
Keyword(s):  
Repeat Dose ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document